ACE and congestive heart failure: This systematic review has several key strengths, notably the exclusive inclusion of randomized controlled trials (RCTs) and clinical trials, which provide the highest level of evidence for evaluating the efficacy and long-term outcomes of beta-blockers and ACE inhibitors in chronic heart failure.